Contact the Host for event and ticket information.

This event has ended!

View current events hosted by New York State Center of Excellence in Bioinformatics & Life Sciences

Life Sciences Commercialization Lecture Series

Monday, September 27, 2010 from 3:30 PM to 5:30 PM (ET)

Buffalo, NY

Life Sciences Commercialization Lecture Series

Ticket Information

Type End     Quantity
Life Sciences Commercialization Lecture Series Ended Free  
Share this!

Event Details

The New Appleseed Fund for Early-Stage Companies -
Life Sciences Commercialization Lecture Series Kick-Off

The fourth season of the Lecture Series starts with a special presentation by the Office of the State Comptroller (OSC), which is announcing new funds for early stage company investment through the Common Retirement Fund's (CRF) In-State Private Equity Investment Program. Come and learn from OSC and others how this breakthrough funding will help our region grow its high-tech economy.

Reception will be provided following the Lecture Series for additional networking opportunities with investors, entrepreneurs, and others.

When & Where



New York State Center of Excellence in Bioinformatics & Life Sciences
701 Ellicott Street
2nd Floor
Buffalo, NY 14203

Monday, September 27, 2010 from 3:30 PM to 5:30 PM (ET)


  Add to my calendar

Hosted By

New York State Center of Excellence in Bioinformatics & Life Sciences



The New York State Center of Excellence in Bioinformatics & Life Sciences (COE) was created in Buffalo, New York in 2002 as part of more than $200 million dollars in investment from state, federal, industry and philanthropic sources to create a hub of life sciences expertise and innovation in Upstate New York. The COE brings a strong foundation in life sciences research and discovery to its mission and collaborative efforts with industry, government and researchers around the world to improve the health and well-being of the population. COE research institutions have been around for more than 100 years with the University at Buffalo (UB) as the lead academic organization, and Roswell Park Cancer Institute and Hauptman-Woodward Medical Research Institute as research partners.